Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Foldamers With Two Distinct Helical Motifs Controlled by Solvent.

Created on 25 Sep 2026

Authors

Yinhui Liao, Vipul Batra, Govinda Prasad Devkota, Annabelle Ryu, Henry S Oliver, David L Tierney, C Scott Hartley

Published in

Chemistry (Weinheim an der Bergstrasse, Germany). Pages e71727. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Abiotic foldamers that switch between distinct, well-defined geometries are rare. Here, we report a structurally simple series of oligomers with alternating ortho-phenylene and 2,3-pyrazinylene repeat units. Deconvolution of variable-temperature 1H NMR spectra, with the help of ab initio chemical shift predictions, shows that the oligomers favor a compact, arene-stacked helix in chloroform but a structurally distinct extended helix in acetone. The longest oligomer investigated, a heptamer, exhibits nearly perfect solvent-switching behavior at low temperature, effectively doubling its length in acetone compared to chloroform. X-ray crystallography confirms that the hybrid backbone is capable of both folding motifs. While arene-arene stacking drives folding in chloroform, nonclassical intramolecular C⁠─H⁠⋯⁠N hydrogen bonds appear to be more important in acetone. Both geometries are enthalpically favored in their respective solvents, highlighting how a balance of weak, competing interactions can be harnessed to achieve large-scale geometry changes in synthetic foldamers.

PMID:
42788635
Bibliographic data and abstract were imported from PubMed on 25 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement